Abstract
Although cancers have been thought to be predominantly driven by acquired genetic changes, it is becoming clear that microenvironment-mediated epigenetic alterations play important roles. Aberrant promoter hypermethylation is a prevalent phenomenon in human cancers as well as malignant lymphoma/leukemia. Tumor suppressor genes become frequent targets of aberrant hypermethylation in the course of gene-silencing due to the increased and deregulated DNA methyltransferases (DNMTs). The purpose of this article is to review the current status of knowledge about the contribution of cumulative epigenetic abnormalities of the host genes after microbial and virus infection to the crisis and progression of malignant lymphoma/leukemia. In addition, the relevance of this knowledge to malignant lymphoma/leukemia assessment, prevention and early detection will be discussed.
Original language | English |
---|---|
Pages (from-to) | 568-581 |
Number of pages | 14 |
Journal | Cancers |
Volume | 3 |
Issue number | 1 |
DOIs | |
Publication status | Published - Mar 2011 |
Keywords
- Epigenetics
- H Pylori
- HTLV-I
- Leukemia
- Lymphoma
- Methylation
- Progression
ASJC Scopus subject areas
- Oncology
- Cancer Research